Tag: kamuvudine_9
-
Modified HIV Drug Reverses Vision Loss and Paralysis in Multiple Sclerosis Model
NIH-funded study finds experimental drug K-9, derived from HIV antivirals, restored sight and movement in mice with MS-like disease, while claims data link NRTIs to fewer MS diagnoses and relapses.
HealthScience & TechnologyUSAMedical ScienceFederal GovernmentLegal Multiple SclerosisKamuvudine-9National Institutes of HealthNational Eye InstituteNRTIsInflammasomeUniversity of Virginia